Skip to main content
letter
. 2020 Jun 24;35(9):2801–2803. doi: 10.1007/s11606-020-05991-z

Table 1.

Baseline Characteristics

CCIS 0 (n = 2911) CCIS 1–2 (n = 1112) CCIS 3–4 (n = 288) CCIS > 4 (n = 169) Total (n = 4480)
Male 1326 (45.6) 559 (50.3) 149 (51.7) 110 (65.1) 2,144 (47.9)
Age [IQR] 47 [35, 58] 71 [56, 81] 78 [67, 85] 77 [69, 83] 55 [41, 72]
CCIS [IQR] 0 [0, 0] 1 [1, 2] 3 [3, 4] 6 [5, 8] 0 [0, 1]
Comorbidities, no. (%)
Myocardial infarction 0 (0.0) 65 (5.8) 40 (13.9) 44 (26.0) 149 (3.3)
Heart failure 0 (0.0) 77 (6.9) 66 (22.9) 55 (32.5) 198 (4.4)
Cerebrovascular disease 0 (0.0) 171 (15.4) 85 (29.5) 50 (29.6) 306 (6.8)
Peripheral vascular disease 0 (0.0) 63 (5.7) 52 (18.1) 45 (26.6) 160 (3.6)
Diabetes with complications 0 (0.0) 38 (3.4) 60 (20.8) 62 (36.7) 160 (3.6)
Diabetes 0 (0.0) 206 (18.5) 102 (35.4) 88 (52.1) 396 (8.8)
Dementia 0 (0.0) 100 (9.0) 36 (12.5) 20 (11.8) 156 (3.5)
Hemi- or paraplegia 0 (0.0) 10 (0.9) 5 (1.7) 6 (3.6) 21 (0.5)
Rheumatic disease 0 (0.0) 71 (6.4) 34 (11.8) 13 (7.7) 118 (2.6)
Peptic ulcer 0 (0.0) 24 (2.2) 19 (6.6) 18 (10.7) 61 (1.4)
COPD 0 (0.0) 306 (27.5) 93 (32.3) 66 (39.1) 465 (10.4)
Chronic renal disease 0 (0.0) 30 (2.7) 57 (19.8) 67 (39.6) 154 (3.4)
Mild liver disease 0 (0.0) 35 (3.1) 11 (3.8) 16 (9.5) 62 (1.4)
Severe liver disease 0 (0.0) 0 (0.0) 8 (2.8) 10 (5.9) 18 (0.4)
Cancer 0 (0.0) 156 (14.0) 106 (36.8) 86 (50.9) 348 (7.8)
Metastatic cancer 0 (0.0) 0 (0.0) 0 (0.0) 49 (29.0) 49 (1.1)
HIV/AIDS 0 (0.0) 0 (0.0) 0 (0.0) * *

CCIS, Charlson comorbidity index score; COPD, chronic obstructive pulmonary disease; IQR, interquartile range. *Low number of observations, blanked to ensure patient anonymity